Article Text

PDF
Migraine prevention
  1. D W Dodick1,
  2. S D Silberstein2
  1. 1
    Professor of Neurology, Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona, USA
  2. 2
    Professor of Neurology, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
  1. Professor D W Dodick, Department of Neurology, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, Arizona 85259, USA; Dodick.David{at}mayo.edu

Abstract

Preventive medications reduce migraine frequency and severity, and improve migraine-specific quality of life. Recent evidence also suggests that these same medications enhance the patient’s response to acute migraine therapies, and may also reduce the likelihood of developing chronic daily headache. However, many patients who should receive or be offered preventive treatment are not. Most patients can be successfully managed when patient and physician expectations are realistic and aligned, the selection of preventive medications is individualised, and the initiation and titration strategy is appropriate and carefully followed. Rational combinations of preventive medications may also be useful. This review provides an evidence and experience-based approach to the preventive treatment of migraine.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.